Advertisement

Future Prospects of Proteolytic Enzymes and Wound Healing

  • W. Westerhof

Abstract

A review of the literature makes it clear that the effects of the various proteolytic enzymes presently on the market have not been sufficiently investigated in double-blind placebo-controlled clinical trials. This is primarily because most of these enzyme preparations were introduced a long time ago, when the regulations of the health authorities were not very strict. Furthermore, the evaluation methods and end-point criteria for a clinical study were not very accurate. Finally, most of the studies suffered a lack of stratification, involving huge numbers of patients, mostly in poorly organized multi center trials. This is now going to change. The Food and Drug Administration of the USA and the Committee for Proprietary Medicinal Products of the FC have set very strict guidelines on the quality, safety, and efficacy of medicinal products for human use. This means that many existing products have to be filed again for registration according to the new guidelines of good clinical, laboratory, and manufacturing practice.

Keywords

Wound Healing Hyaluronic Acid Proteolytic Enzyme Enzyme Preparation Wound Debridement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hellgren L, Vincent J (1993) Evaluation techniques for the assessment of wound healing. In: Westerhof W (ed) Leg ulcers: diagnosis and treatment, Elsevier Science Publishers Amsterdam, pp 381–384Google Scholar
  2. 2.
    Mekkes JR, Westerhof W, van Rietpaap E, Estevez O (1993) A new computer image analysis system designed for evaluating wound débriding products. In: Proc. of meeting on advances in wound management (Oktober 20–23 1992, Harrogate, Harding KG et al. (eds). MacMillan Magazines, London, pp 4–7Google Scholar
  3. 3.
    Westerhof W, Mekkes JR, Le Poole IC, Das PK (1993) Research on leg ulcers. In: Westerhof W (ed) Leg ulcers: diagnosis and treatment. Elsevier Science Publishers, Amsterdam, pp 385–399Google Scholar
  4. 4.
    Le Poole IC, Das PK, Krieg SR, Mekkes JR, Westerhof W (1991) Organotypic culture of human skin for studying wound healing. Wounds 3: 102–110Google Scholar
  5. 5.
    Le Poole IC, Das PK, Dingemans KP, de Boer OJ, Boschman GA, Mekkes JR, Westerhof W (1990) In vitro effect of “krill enzymes” on skin cell types related to wound healing. Wounds 2: 163–169Google Scholar
  6. 6.
    Mekkes JR, Westerhof W, Le Poole IC, Das PK (1990) Proteolytic débridement of necrotic wounds using krill enzymes in a pig model. J Invest Dermatol 95: 480Google Scholar
  7. 7.
    Westerhof W, Mekkes JR (1990) Krill and other enzymes in enzymatic wound débridement. In: Wadström T et al. (eds) Pathogenesis of wound and biomaterial-associated infections. Springer, Berlin Heidelberg New York, pp 179–188Google Scholar
  8. 8.
    Dixon M et al (1984) International Union of Biochemistry (Nomenclature Committee). Enzyme Nomenclature 1984. Academic, LondonGoogle Scholar
  9. 9.
    Mosback K (1976) Immobilized enzymes appeared in Methods in enzymology. vol XLIV. Academic, New YorkGoogle Scholar
  10. 10.
    Dutrieux RP, Van Ginkel CJW, Westerhof W (1989) Toepassing van groeifactoren bij wondgenezing: fictie of realiteit? Ned Tijdschr Geneesk 133: 1870–1872Google Scholar
  11. 11.
    Sher W (1987) The role of extracellular proteases in cell proliferation and differentiation. Lab Invest 57: 607–633Google Scholar
  12. 12.
    Burger M (1970) Proteolytic enzymes initiating cell division and escape from contact inhibition of growth. Nature 227: 170–171PubMedCrossRefGoogle Scholar
  13. 13.
    Kodama S, Kishi J, Obata K, iwata K, Hayakawa T (1987) Monoclonal antibodies to bovine inhibitor. Coll Relat Res 7: 341–350PubMedGoogle Scholar
  14. 14.
    Nakamura T, Takagaki K, Kubo K, Morikawa A, Tamura S, Endo M (1990) Extracellular depolymerisation of hyaluronic acid in cultured human skin fibroblasts. Biochem Biophys Res Commun 172: 70–76PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • W. Westerhof
    • 1
  1. 1.Department of Dermatology, Academic Medical CenterUniversity of AmsterdamThe Netherlands

Personalised recommendations